This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Treatment of Cognitive Deficits in Schizophrenia With Atomoxetine: A Case Report

Naren P. Rao, MBBS; Ganesan Venkatasubramanian, MBBS, MD; and Bangalore N. Gangadhar, MBBS, MD

Published: December 14, 2007

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Schizophrenia patients have deficits in attention, concentration, and information processing that result in significant functional impairment.1 Atomoxetine, a novel cognitive enhancer that can reduce executive function deficits,2 has been postulated to potentially treat these deficits in schizophrenia.3 We report a patient with schizophrenia whose cognitive functioning improved after adjunctive treatment with atomoxetine.’ ‹’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 68

Quick Links: Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional...